跳至主要内容
临床试验/CTRI/2025/05/087721
CTRI/2025/05/087721尚未招募不适用

To Study The Prevalence Of Polypharmacy Among Patients With Hypertension At Tertiary Care Hospital In North India

Department of pharmacology Government medical college,Patiala1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2025年10月6日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
92
试验地点
1
主要终点
To assess the prevalence of Polypharmacy Among hypertensive patients attending out patient department of medicine.

研究概览

简要总结

Polypharmacy is associated with drug–drug or food–drug interactions that may pose treatment difficulties. The effects of polypharmacy are numerous and should concern physicians and policy makers both in terms of finances (due to significant health costs) and medical consequences (due to multiple drug interactions).The aim of this study is to evaluate the prevalence of polypharmacy among hypertensive patients at tertiary care hospital in North India.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • •Individuals having systolic blood pressure of 140-179mmHg and diastolic blood pressure of 90-109mmHg.
  • •Hypertensive patients.
  • •Hypertensive patients with co morbid conditions such as diabetes mellitus etc.

排除标准

  • •Patients who did not give informed consent.
  • •Patients less than 18 years and more than 80 years old.
  • •Patients with severe illness such as chronic kidney disease, malignancy.
  • •Pregnant and lactating women.

结局指标

主要结局

To assess the prevalence of Polypharmacy Among hypertensive patients attending out patient department of medicine.

时间窗: 3 months

次要结局

未报告次要终点

研究者

发起方
Department of pharmacology Government medical college,Patiala
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验